SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-096971
Filing Date
2021-07-28
Accepted
2021-07-28 16:26:37
Documents
14
Period of Report
2021-07-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2123449d1_8k.htm   iXBRL 8-K 24668
2 EXHIBIT 99.1 tm2123449d1_ex99-1.htm EX-99.1 93435
3 GRAPHIC tm2123449d1_ex99-1img001.jpg GRAPHIC 4040
  Complete submission text file 0001104659-21-096971.txt   308924

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA inva-20210728.xsd EX-101.SCH 3176
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20210728_lab.xml EX-101.LAB 34593
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20210728_pre.xml EX-101.PRE 22704
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2123449d1_8k_htm.xml XML 3609
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 211122845
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences